|
TQGYFPDWQNYTPGPGVRYPLTFGWCYKLVP
|
Nef(117-147)
|
human epitope
|
QGYFPDWQNYTPGPGVRY
|
Nef(118-135)
|
C*16 human epitope
|
QGYFPDWQNYTPGPGIRY
|
Nef(118-135)
|
human epitope
|
QGYFPDWQNYTPGPGRF
|
Nef(118-135)
|
human epitope
|
QGYFPDWQNYTPGPvRy
|
Nef(118-135)
|
subtype-specific susceptible form
|
QGYFPDWQNYTPGPGIRY
|
Nef(118-135)
|
human epitope
|
YFPDWQNYTPGPGIR
|
Nef(120-134)
|
human epitope
|
YFPDWQNYTPGPGIRYPLTFGWCYK
|
Nef(120-144)
|
A24 human epitope
|
FPDWQNYTPGPGIRY
|
Nef(121-135)
|
A*02:01 human epitope
|
FPDWQNYTPGPGIRY
|
Nef(121-135)
|
A24 human epitope
|
FPDWQNYTPGPGIRY
|
Nef(121-135)
|
human epitope
|
FPDWQNYTPGPGIRYPLT
|
Nef(121-138)
|
human epitope
|
FPDWQNYTPGPGIRYPLT
|
Nef(121-138)
|
human epitope
|
FPDWQNYTPGPGtRYPLT
|
Nef(121-138)
|
observed variant
|
PDWQNYTPGPGVRYP
|
Nef(122-136)
|
human epitope
|
PDWQNYTPGPGVRYPLTFGW
|
Nef(122-141)
|
B*35 human epitope
|
PDWQNYTPGPGVRYPLTFGW
|
Nef(122-141)
|
human epitope
|
QWQNYTPGPGVRYPL
|
Nef(123-137)
|
human epitope
|
WQNYTPGPGIRYPLT
|
Nef(124-138)
|
human epitope
|
WQNYTPGPGIRYPLT
|
Nef(124-138)
|
human epitope
|
QNYTPGPGIRYPLTF
|
Nef(125-139)
|
A*02:01 human epitope
|
QNYTPGPGVRYPLTF
|
Nef(125-139)
|
human epitope
|
QNYTPGPGRFPLTFGWCF
|
Nef(125-143)
|
human epitope
|
QNYTPGPGvRyPLTFGWCF
|
Nef(125-143)
|
subtype-specific susceptible form
|
NYTPGPGVRY
|
Nef(126-135)
|
A24 human epitope
|
NYTPGPGIRY
|
Nef(126-135)
|
A*24:02 human epitope
|
NYTPGPGvRY
|
Nef(126-135)
|
observed variant
|
cYTPGPGtRY
|
Nef(126-135)
|
observed variant
|
NYTPGPGtRY
|
Nef(126-135)
|
observed variant
|
NYTPGPGIRf
|
Nef(126-135)
|
observed variant
|
NYTPGPGtRf
|
Nef(126-135)
|
observed variant
|
cYTPGPGIRf
|
Nef(126-135)
|
observed variant
|
gYTPGPGIRf
|
Nef(126-135)
|
observed variant
|
cYTPGPGtRf
|
Nef(126-135)
|
observed variant
|
gYTPGPGtRf
|
Nef(126-135)
|
observed variant
|
NYTPGPGvRf
|
Nef(126-135)
|
observed variant
|
NYTPGPGeRf
|
Nef(126-135)
|
observed variant
|
NYTPGPGvRl
|
Nef(126-135)
|
observed variant
|
NYTPGPGtRw
|
Nef(126-135)
|
observed variant
|
NYTPGPGIRY
|
Nef(126-135)
|
A*24:02 human epitope
|
NYTPGPGVRYPLT
|
Nef(126-138)
|
B*07 human epitope
|
NYTPGPGVRYPLT
|
Nef(126-138)
|
B7 human epitope
|
NYTPGPGTRYPLTFG
|
Nef(126-140)
|
A24 human epitope
|
NYTPGPGTRYPLTFG
|
Nef(126-140)
|
B35 human epitope
|
NYTPGPGTRYPLTFG
|
Nef(126-140)
|
human epitope
|
NYTPGPGVRYPLTFGWCF
|
Nef(126-143)
|
C*14 human epitope
|
NYTPGPGIRYPLCFGWCF
|
Nef(126-143)
|
human epitope
|
NYTPGPGIRYPLTFGWCF
|
Nef(126-143)
|
human epitope
|
NYTPGPGIRYPLTFGWCF
|
Nef(126-143)
|
human epitope
|
YTPGPGIRY
|
Nef(127-135)
|
A*23 human epitope
|
YTPGPGIRY
|
Nef(127-135)
|
A*24 human epitope
|
YTPGPGIRY
|
Nef(127-135)
|
B*35:02, B*35:03, B*53:01 human epitope
|
YTPGPGIRY
|
Nef(127-135)
|
B*57 human epitope
|
YTPGPGIRY
|
Nef(127-135)
|
B*57 human epitope
|
YTPGPGIRY
|
Nef(127-135)
|
B57, B58 human epitope
|
YTPGPGVRY
|
Nef(127-135)
|
B*58:01 human epitope
|
YTPGPGIRY
|
Nef(127-135)
|
B*63 human epitope
|
YTPGPGIRY
|
Nef(127-135)
|
human epitope
|
YTPGPGIRY
|
Nef(127-135)
|
human epitope
|
YTPGPGTRY
|
Nef(127-135)
|
human epitope
|
YTPGPGVRY
|
Nef(127-135)
|
human epitope
|
YTPGPGVRYPLTFGW
|
Nef(127-141)
|
A24 human epitope
|
YTPGPGVRYPLTFGW
|
Nef(127-141)
|
B35 human epitope
|
YTPGPGVRYPLTFGW
|
Nef(127-141)
|
human epitope
|
TPGPGVRY
|
Nef(128-135)
|
B*07:02 human epitope
|
TPGPGVRY
|
Nef(128-135)
|
B7 supertype human epitope
|
TPGPGVRYP
|
Nef(128-136)
|
B*07 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*07 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*07 human epitope
|
TPGPGVKYPL
|
Nef(128-137)
|
B*07 human, transgenic mouse epitope
|
TPGPGiKYPL
|
Nef(128-137)
|
susceptible form
|
TPGPGVRYPL
|
Nef(128-137)
|
B*07 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*07 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*07 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*07 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*07 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*07, B*42 human epitope
|
TPGPGTRYPL
|
Nef(128-137)
|
B*07:02 human epitope
|
TPGPGiRYPL
|
Nef(128-137)
|
non-susceptible form
|
TPGPGvRYPL
|
Nef(128-137)
|
diminished response; escape documented in this paper; non-susceptible form; susceptible form
|
TPGPGTRfPL
|
Nef(128-137)
|
diminished response; escape documented in this paper; non-susceptible form; susceptible form
|
TPGPGVRYPL
|
Nef(128-137)
|
B*07:02 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*07:02 human epitope
|
TPGPGIRYPL
|
Nef(128-137)
|
B*07:02 human epitope
|
TPGPGvRYPL
|
Nef(128-137)
|
subtype-specific susceptible form
|
TPGPGVRYPL
|
Nef(128-137)
|
B*07:02 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*07:02 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*07:02 human epitope
|
TPGPGIRYPL
|
Nef(128-137)
|
B*07:02 human epitope
|
TPGPGvRYPL
|
Nef(128-137)
|
susceptible form
|
TPGPGVRYPL
|
Nef(128-137)
|
B*07:02 human epitope
|
TPGPGIRYPL
|
Nef(128-137)
|
B*07:02 human epitope
|
TPGPGvRYPL
|
Nef(128-137)
|
diminished response; escape documented in this paper; susceptible form
|
TPGPGvRfPL
|
Nef(128-137)
|
diminished response; escape documented in this paper; susceptible form
|
TPGPGvRwPL
|
Nef(128-137)
|
diminished response; escape documented in this paper; susceptible form
|
TPGPGvRlPL
|
Nef(128-137)
|
diminished response; escape documented in this paper; susceptible form
|
TPGPGtRfPL
|
Nef(128-137)
|
diminished response; escape documented in this paper; susceptible form
|
TPGPGVRYPL
|
Nef(128-137)
|
B*07:02, B*42:01 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*07:02, B7 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B35 human epitope
|
TPGPGTRYPL
|
Nef(128-137)
|
B35 human epitope
|
TPGPGvRYPL
|
Nef(128-137)
|
susceptible form
|
TPGPGVRYPL
|
Nef(128-137)
|
B35 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*35:01 human epitope
|
TsGPGVRYPL
|
Nef(128-137)
|
susceptible form
|
TPGPGVRYPL
|
Nef(128-137)
|
B*35:02, B*35:03, B*53:01 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*42 human epitope
|
TPGPGIRYPL
|
Nef(128-137)
|
B42 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*42:01 human epitope
|
TsGPGVRYPL
|
Nef(128-137)
|
diminished HLA binding or increased off-rate; escape documented in this paper
|
TqGPGVRYPL
|
Nef(128-137)
|
diminished HLA binding or increased off-rate; escape documented in this paper
|
TPGPGVRYPL
|
Nef(128-137)
|
B*42:01 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*42:01 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*42:01 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*42:01 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*42:01 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*42:01, B*42:02 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*42:02 epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 human, macaque epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 human epitope
|
TPGPGiRYPL
|
Nef(128-137)
|
observed variant
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 human epitope
|
TPGPGiRYPL
|
Nef(128-137)
|
observed variant
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 human epitope
|
TPGPGiRYPL
|
Nef(128-137)
|
susceptible form
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 human epitope
|
TPGPGIRYPL
|
Nef(128-137)
|
B7 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*81:01, B7 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*81:01, B7 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B7 supertype human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
B*81:01 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
C*17 human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
human epitope
|
TPGPGIRYPL
|
Nef(128-137)
|
human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
human epitope
|
TPGPGVRYPL
|
Nef(128-137)
|
human epitope
|
TPGPGTRYPL
|
Nef(128-137)
|
human epitope
|
TPGPGIRFPL
|
Nef(128-137)
|
susceptible form
|
TPGPGIRYPL
|
Nef(128-137)
|
susceptible form
|
TPGPGIRYPV
|
Nef(128-137)
|
susceptible form
|
TPGPGIRFPI
|
Nef(128-137)
|
susceptible form
|
TSGPGTRFPL
|
Nef(128-137)
|
susceptible form
|
IPGPG-RHPL
|
Nef(128-137)
|
observed variant
|
TPGPGVRYPL
|
Nef(128-137)
|
observed variant
|
TPGPGPRYPL
|
Nef(128-137)
|
susceptible form
|
TPGPGTRFPL
|
Nef(128-137)
|
observed variant
|
TPGPGPRFPL
|
Nef(128-137)
|
observed variant
|
TPGPGIRYPM
|
Nef(128-137)
|
susceptible form
|
TPGPGPRYPV
|
Nef(128-137)
|
susceptible form
|
TPGPGPRYPM
|
Nef(128-137)
|
susceptible form
|
TKGPGIRFPL
|
Nef(128-137)
|
susceptible form
|
TPGPGPRYPM
|
Nef(128-137)
|
susceptible form
|
TPGPGIRYPL
|
Nef(128-137)
|
human epitope
|
TPGPGvRYPL
|
Nef(128-137)
|
HLA association; susceptible form
|
TPGPGRFPL
|
Nef(128-137)
|
human epitope
|
TPGPGvryPL
|
Nef(128-137)
|
observed variant
|
TPGPGIRYPLTFGW
|
Nef(128-141)
|
human epitope
|
TPGPGIRYPLTFGW
|
Nef(128-141)
|
human epitope
|
TPGPGIRYPLTFGW
|
Nef(128-141)
|
human epitope
|
PGPGTRFPLTFGWCF
|
Nef(129-143)
|
A23 human epitope
|
PGPGTRFPLTFGWCF
|
Nef(129-143)
|
A24 human epitope
|
PGPGIRYPLCFGWCF
|
Nef(129-143)
|
B35 human epitope
|
PGPGTRFPLTFGWCF
|
Nef(129-143)
|
B35 human epitope
|
PGPGIRYPLTFGWCF
|
Nef(129-143)
|
B57 human epitope
|
PGPGIRYPLTFGWCF
|
Nef(129-143)
|
human epitope
|
PGPGpRYPLTFGWCF
|
Nef(129-143)
|
non-susceptible form; susceptible form
|
PGPGIRYPLTFGWCF
|
Nef(129-143)
|
human epitope
|
PGPGtRfPLTFGWCF
|
Nef(129-143)
|
observed variant
|
PGPGVRYPLTFGWCFKLV
|
Nef(129-146)
|
human epitope
|
PGPGIRYPLTFGWCFKLV
|
Nef(129-146)
|
human epitope
|
PGPGVRYPLTFGWCFKLVP
|
Nef(129-147)
|
human epitope
|
GPGVRYPLTF
|
Nef(130-139)
|
B35 human epitope
|
GPGVRYPLTF
|
Nef(130-139)
|
B35 human epitope
|
GPGTRFPLTR
|
Nef(130-139)
|
B7 human epitope
|
GPGVRYPLTFGWCY
|
Nef(130-143)
|
B*57 human epitope
|
GPGVRYPLTFGWCY
|
Nef(130-143)
|
B*57 human epitope
|
GPGIRYPLTFGWCF
|
Nef(130-143)
|
B*57 human epitope
|
GPGVRYPLTFGWCY
|
Nef(130-143)
|
B57 human epitope
|
GPGIRYPLTFGWCF
|
Nef(130-143)
|
B*58:01, B57 human epitope
|
GPGVRYPLTFGWCYK
|
Nef(130-144)
|
human epitope
|
GPGTRFPLTFGWCFKLV
|
Nef(130-146)
|
human epitope
|
PGIRYPLTFGWCFKL
|
Nef(131-145)
|
A23 human epitope
|
PGIRYPLTFGWCFKL
|
Nef(131-145)
|
A24 human epitope
|
PGIRYPLTFGWCFKL
|
Nef(131-145)
|
B35 human epitope
|
PGIRYPLTFGWCFKL
|
Nef(131-145)
|
human epitope
|
PGIRYPLTFGWCFKL
|
Nef(131-145)
|
human epitope
|
PGIRYPLTFGWCFKL
|
Nef(131-145)
|
human epitope
|
PGIRYPLTFGWCFKL
|
Nef(131-145)
|
human epitope
|
PGIRYPLTFGWCFKLVPVEP
|
Nef(131-150)
|
human epitope
|
GIRYPLTFGWCFK
|
Nef(132-144)
|
human epitope
|
GvRYPLTFGWCFK
|
Nef(132-144)
|
observed variant
|
GIRYPLcFGWCFK
|
Nef(132-144)
|
observed variant
|
GVRYPLTLGWCFKLV
|
Nef(132-146)
|
A24 human epitope
|
GVRYPLTFGWCYKLVP
|
Nef(132-147)
|
A1, B8 human epitope
|
GVRYPLTFGWCYKLVP
|
Nef(132-147)
|
B18 human epitope
|
GVRYPLTFGWCYKLVP
|
Nef(132-147)
|
H-2d mouse epitope
|
GIRYPLTFGWCFKLVP
|
Nef(132-147)
|
human epitope
|
GVRYPLTFGWCYKLVPVEPD
|
Nef(132-151)
|
human epitope
|
TRYPLTFGW
|
Nef(133-141)
|
A*03 human epitope
|
TRYPLTFGW
|
Nef(133-141)
|
A*23 human epitope
|
TRYPLTFGW
|
Nef(133-141)
|
A*24 human epitope
|
TRYPLTFGW
|
Nef(133-141)
|
A*29 human epitope
|
TRYPLTFGW
|
Nef(133-141)
|
A*33 human epitope
|
TRYPLTFGW
|
Nef(133-141)
|
A33 human epitope
|
TRYPLTFGW
|
Nef(133-141)
|
A33 human epitope
|
TRYPLTFGW
|
Nef(133-141)
|
A*68:02 human epitope
|
TRYPLTFGW
|
Nef(133-141)
|
B*18 human epitope
|
VRYPLTFGW
|
Nef(133-141)
|
B27 human epitope
|
VRYPLTFGW
|
Nef(133-141)
|
B*27:02 human epitope
|
VRYPLTFGW
|
Nef(133-141)
|
B*27:05 human epitope
|
TRYPLTFGW
|
Nef(133-141)
|
B*35:01, B*35:08 human epitope
|
TRYPLTFGW
|
Nef(133-141)
|
B*35:02, B*35:03, B*53:01 human epitope
|
TRYPLTFGW
|
Nef(133-141)
|
B*42:01 human epitope
|
VRYPLTFGW
|
Nef(133-141)
|
C*04:01 human epitope
|
VRYPLTFGW
|
Nef(133-141)
|
human epitope
|
TRYPLTFGW
|
Nef(133-141)
|
human epitope
|
VRYPLTFGW
|
Nef(133-141)
|
human epitope
|
GRFPLTFGW
|
Nef(133-141)
|
human epitope
|
tRyPLTFGW
|
Nef(133-141)
|
observed variant
|
IRYPLTFGWC
|
Nef(133-142)
|
B*27 human epitope
|
TRYPLTFGWCYKLVP
|
Nef(133-147)
|
A24 human epitope
|
TRYPLTFGWCYKLVP
|
Nef(133-147)
|
B35 human epitope
|
IRYPLTFGWCFKLVP
|
Nef(133-147)
|
human epitope
|
pRYPLTFGWCFKLVP
|
Nef(133-147)
|
non-susceptible form; susceptible form
|
VRYPLTFGWCYKLVPV
|
Nef(133-148)
|
B57 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*23 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A23, A24, B35, B53 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*23:01 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*23:01 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*23:01, A24 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*23:01, A*24:02 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*24 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*24 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*24 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*24 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*24 human epitope
|
RfPLTFGW
|
Nef(134-141)
|
escape documented in this paper
|
RYPLTFGW
|
Nef(134-141)
|
A*24 human epitope
|
RFPLTFGW
|
Nef(134-141)
|
A*24 human epitope
|
RyPLTFGW
|
Nef(134-141)
|
susceptible form
|
RyPLcFGW
|
Nef(134-141)
|
susceptible form
|
RyPLTlGW
|
Nef(134-141)
|
escape documented in this paper
|
RYPLTFGW
|
Nef(134-141)
|
A*24 human epitope
|
RfPLTFGW
|
Nef(134-141)
|
diminished HLA binding or increased off-rate; diminished response
|
RYPLcFGW
|
Nef(134-141)
|
diminished response
|
RYPLTlGW
|
Nef(134-141)
|
escape documented in this paper
|
RYPLTFGW
|
Nef(134-141)
|
A*24 human epitope
|
{PGPGT}RYPLTlGW{CFKLV}
|
Nef(134-141)
|
non-susceptible form; observed variant
|
{PGPGT}RYPLmFGW{CFKLV}
|
Nef(134-141)
|
observed variant; susceptible form
|
{PGPGi}RfPLTFGW{CFKLV}
|
Nef(134-141)
|
observed variant; susceptible form
|
RYPLTFGW
|
Nef(134-141)
|
A*24 human epitope
|
RYPLmFGW
|
Nef(134-141)
|
escape documented in this paper; observed variant
|
RYPLTlGW
|
Nef(134-141)
|
escape documented in this paper; observed variant
|
RfPLTFGW
|
Nef(134-141)
|
escape documented in this paper; observed variant
|
RYPLTFGW
|
Nef(134-141)
|
A*24 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A24 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A24 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A24 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A24 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A24 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*24:02 human epitope
|
RfPLTFGW
|
Nef(134-141)
|
observed variant
|
RfPiTFGW
|
Nef(134-141)
|
observed variant
|
RYPiTFGW
|
Nef(134-141)
|
observed variant
|
RYPLTFGW
|
Nef(134-141)
|
A*24:02 human epitope
|
RfPLTFGW
|
Nef(134-141)
|
altered KIR binding or increased/decreased off-rate
|
RYPLTFGa
|
Nef(134-141)
|
susceptible form
|
RYPLTFGW
|
Nef(134-141)
|
A*24:02 human epitope
|
RfPLTFGW
|
Nef(134-141)
|
susceptible form
|
RYPLTlGW
|
Nef(134-141)
|
non-susceptible form
|
RYPLcFGW
|
Nef(134-141)
|
non-susceptible form
|
RfPLcFGW
|
Nef(134-141)
|
non-susceptible form
|
RYPLTFGW
|
Nef(134-141)
|
A*24:02 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*24:02 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*24:02 human epitope
|
RfPLTFGW
|
Nef(134-141)
|
TCR related mutation
|
RYPLTFGW
|
Nef(134-141)
|
A*24:02 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*24:02 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*24:02 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*24:02 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*24:02 human epitope
|
RfPLTFGW
|
Nef(134-141)
|
diminished HLA binding or increased off-rate
|
RYPLTFGW
|
Nef(134-141)
|
A*24:02 human epitope
|
RfPLTFGW
|
Nef(134-141)
|
diminished response; escape documented in this paper; non-susceptible form; susceptible form
|
RYPLcFGW
|
Nef(134-141)
|
diminished response; escape documented in this paper; non-susceptible form; susceptible form
|
RYPLTFGW
|
Nef(134-141)
|
A*24:02 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*24:02 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A*29 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
A33 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
B*18 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
B*27 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
B27 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
B27 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
B*35:02, B*35:03, B*53:01 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
C*04 human epitope
|
RYPLTFGW
|
Nef(134-141)
|
human epitope
|
RFPLTFGW
|
Nef(134-141)
|
human epitope
|
RyPLTFGW
|
Nef(134-141)
|
observed variant
|
RYPLTFGW
|
Nef(134-141)
|
human epitope
|
RYPLTFGWCF
|
Nef(134-143)
|
A*23:01 human epitope
|
RYPLTFGWCF
|
Nef(134-143)
|
A*23:01 human epitope
|
RYPLTFGWCF
|
Nef(134-143)
|
A*23:01, A*24 human epitope
|
RfPLTFGWCF
|
Nef(134-143)
|
altered HLA expression; observed variant
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24 human epitope
|
RYPLTFGWCy
|
Nef(134-143)
|
observed variant
|
RYPLTFGWCY
|
Nef(134-143)
|
A*24 human epitope
|
RYPLcFGWCY
|
Nef(134-143)
|
observed variant
|
RYPLcFGWCf
|
Nef(134-143)
|
observed variant
|
RfPLcFGWCf
|
Nef(134-143)
|
observed variant
|
R(f)YPLcFGWCf
|
Nef(134-143)
|
observed variant
|
RYPLcF(a)GWCf
|
Nef(134-143)
|
observed variant
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24 human epitope
|
RfPLTFGWCF
|
Nef(134-143)
|
diminished response
|
RYPLcFGWCF
|
Nef(134-143)
|
diminished response
|
RYPLTlGWCF
|
Nef(134-143)
|
escape documented in this paper
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24 human epitope
|
RYPLcFGWCF
|
Nef(134-143)
|
subtype-specific susceptible form
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24 human epitope
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24 human epitope
|
RfPLTFGWCF
|
Nef(134-143)
|
literature escape; observed variant
|
kfPLTFGWCF
|
Nef(134-143)
|
observed variant
|
RYPLTlGWCF
|
Nef(134-143)
|
inferred escape
|
RYPLTFGWCY
|
Nef(134-143)
|
A*24 human epitope
|
RYPLTFGWCf
|
Nef(134-143)
|
observed variant
|
RYPLTFGWCY
|
Nef(134-143)
|
A24 human epitope
|
RYPLTFGWCY
|
Nef(134-143)
|
A24 human epitope
|
RYPLTFGWCF
|
Nef(134-143)
|
A24 human epitope
|
RYPLTFGWCY
|
Nef(134-143)
|
A24 human epitope
|
RYPLTFGWCY
|
Nef(134-143)
|
A24, B35 human epitope
|
RYPLTFGWCf
|
Nef(134-143)
|
observed variant
|
RfPLTFGWCf
|
Nef(134-143)
|
observed variant
|
RYPLTyGWCf
|
Nef(134-143)
|
observed variant
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24:02 human epitope
|
RfPLTFGWCF
|
Nef(134-143)
|
diminished HLA binding or increased off-rate
|
RYPLTlGWCF
|
Nef(134-143)
|
observed variant
|
RYPLTFGWCy
|
Nef(134-143)
|
observed variant
|
RfPLTFGWCy
|
Nef(134-143)
|
observed variant
|
RYPLTFGWpF
|
Nef(134-143)
|
observed variant
|
RfPLTFGWpF
|
Nef(134-143)
|
observed variant
|
RxPLTFGWpF
|
Nef(134-143)
|
observed variant
|
RYPiTFGWCF
|
Nef(134-143)
|
observed variant
|
RfPmTFGWCF
|
Nef(134-143)
|
observed variant
|
RYPcTFGWCF
|
Nef(134-143)
|
observed variant
|
RfPcTFGWCF
|
Nef(134-143)
|
observed variant
|
RwPLTFGWCF
|
Nef(134-143)
|
observed variant
|
RYPLTFGWCY
|
Nef(134-143)
|
A*24:02 human epitope
|
RfPLTFGWCY
|
Nef(134-143)
|
escape documented in this paper
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24:02 human epitope
|
RFPLTFGWCF
|
Nef(134-143)
|
literature escape; susceptible form; TCR related mutation
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24:02 human epitope
|
RfPLTFGWCF
|
Nef(134-143)
|
escape documented in this paper
|
RYPLTFGWCy
|
Nef(134-143)
|
observed variant
|
RYPLcFGWCF
|
Nef(134-143)
|
observed variant
|
RfPLcFGWCF
|
Nef(134-143)
|
observed variant
|
RfPLlFGWCF
|
Nef(134-143)
|
observed variant
|
RfPiTFGWCF
|
Nef(134-143)
|
observed variant
|
RYPLTFGWpF
|
Nef(134-143)
|
observed variant
|
RlPLTFGWCF
|
Nef(134-143)
|
observed variant
|
RfPLTFGWsF
|
Nef(134-143)
|
observed variant
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24:02 human epitope
|
RfPLTFGWCF
|
Nef(134-143)
|
inferred escape; literature escape; replicative capacity reduced
|
RYPiTFGWCF
|
Nef(134-143)
|
observed variant
|
RfPiTFGWCF
|
Nef(134-143)
|
observed variant
|
RfPLcFGWCF
|
Nef(134-143)
|
observed variant
|
RYPLcFGWCF
|
Nef(134-143)
|
inferred escape; literature escape
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24:02 human epitope
|
RYPLTFGWCY
|
Nef(134-143)
|
A*24:02 human epitope
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24:02 human epitope
|
RfPLTFGWCF
|
Nef(134-143)
|
escape documented in this paper; observed variant
|
RfPLcFGWCF
|
Nef(134-143)
|
escape documented in this paper; observed variant
|
RlPLTFGWCF
|
Nef(134-143)
|
observed variant
|
RwPLTFGWCF
|
Nef(134-143)
|
observed variant
|
RYPLTFGWCy
|
Nef(134-143)
|
observed variant
|
RYPLTlGWCF
|
Nef(134-143)
|
observed variant
|
RYPLTlGWCy
|
Nef(134-143)
|
observed variant
|
RYPLTFGWpF
|
Nef(134-143)
|
observed variant
|
RYPLcFGWCF
|
Nef(134-143)
|
observed variant
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24:02 human epitope
|
RfPLTFGWCF
|
Nef(134-143)
|
escape documented in this paper; processing
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24:02 human epitope
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24:02 human epitope
|
RYPLTFGWCY
|
Nef(134-143)
|
A*24:02 human epitope
|
RYPLCFGWCF
|
Nef(134-143)
|
A*24:02 human epitope
|
RYPLtFGWCF
|
Nef(134-143)
|
subtype-specific susceptible form
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24:02 human epitope
|
RYPLcFGWCF
|
Nef(134-143)
|
subtype-specific susceptible form
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24:02 human epitope
|
RfPLTFGWCF
|
Nef(134-143)
|
observed variant
|
RfPiTFGWCF
|
Nef(134-143)
|
observed variant
|
RYPiTFGWCF
|
Nef(134-143)
|
observed variant
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24:02 human epitope
|
RfPLTFGWCF
|
Nef(134-143)
|
TCR related mutation
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24:02 human epitope
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24:02 human epitope
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24:02 human epitope
|
RYPLTFGWCF
|
Nef(134-143)
|
A*24:02 human epitope
|
RYPLTFGWCF
|
Nef(134-143)
|
B*35 human epitope
|
RYPLTFGWCY
|
Nef(134-143)
|
C*07 human epitope
|
RYPLTFGWCY
|
Nef(134-143)
|
C*07:02 human epitope
|
RYPLTFGWCY
|
Nef(134-143)
|
C*07:02 human epitope
|
RYPLTFGWCf
|
Nef(134-143)
|
HLA binding unchanged
|
RYPLTFGWC-
|
Nef(134-143)
|
diminished HLA binding or increased off-rate
|
RfPLTFGWCY
|
Nef(134-143)
|
diminished HLA binding or increased off-rate
|
RlPLTFGWCY
|
Nef(134-143)
|
diminished HLA binding or increased off-rate
|
--PLTFGWCf{kl}
|
Nef(134-143)
|
diminished HLA binding or increased off-rate
|
RYPLTFGWCF
|
Nef(134-143)
|
human epitope
|
RYPLTFGWCF
|
Nef(134-143)
|
human epitope
|
RYPLTFGWCF
|
Nef(134-143)
|
human epitope
|
--PLTFGWCyKL
|
Nef(134-143)
|
HLA association; susceptible form
|
-fPLTFGWCG
|
Nef(134-143)
|
HLA association; susceptible form
|
-YPLTFGWCy
|
Nef(134-143)
|
HLA association; susceptible form
|
{t}RYPLTFGW
|
Nef(134-143)
|
HLA association; susceptible form
|
RYPLTFGWCYK
|
Nef(134-144)
|
B18 human epitope
|
RYPLTFGWCYK
|
Nef(134-144)
|
B18 human epitope
|
RYPLcFGWCYK
|
Nef(134-144)
|
escape documented in this paper
|
RYPLTFGWCFKLVPV
|
Nef(134-148)
|
human epitope
|
RYPLTFGWCFKLVPV
|
Nef(134-148)
|
human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
A2 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
A*23 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
A*23 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
A*24 human epitope
|
FPLTFGWCF
|
Nef(135-143)
|
A*24:02 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B*07, B*35 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B*07:02 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B*07:02 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*07:02, B*18:01 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B*18 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B*18 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*18 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*18 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*18 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*18, B*35 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B18 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B18 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B18 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B18 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B18 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B18 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B18 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B18 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B18, B35 human epitope
|
fPLTFGWCF
|
Nef(135-143)
|
susceptible form; subtype-specific susceptible form
|
YPLcFGWCF
|
Nef(135-143)
|
susceptible form; subtype-specific susceptible form
|
fPLcFGWCF
|
Nef(135-143)
|
susceptible form; subtype-specific susceptible form
|
YPLTFGWCy
|
Nef(135-143)
|
susceptible form; subtype-specific susceptible form
|
YPLTlGWCF
|
Nef(135-143)
|
non-susceptible form; susceptible form; subtype-specific non-susceptible form
|
YPLTFGWCY
|
Nef(135-143)
|
B18, B35, B49, B53, B7 human epitope
|
YPLTFGWCf
|
Nef(135-143)
|
susceptible form
|
YPLTFGWCF
|
Nef(135-143)
|
B*53:01, B18, B35 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B18, B49 human epitope
|
YPLTFGWCf
|
Nef(135-143)
|
susceptible form
|
YPLTFGWCY
|
Nef(135-143)
|
B18, B53, B7 human epitope
|
YPLTFGWCf
|
Nef(135-143)
|
observed variant
|
fPLTFGWCf
|
Nef(135-143)
|
observed variant
|
YPLTyGWCf
|
Nef(135-143)
|
observed variant
|
YPLTFGWCF
|
Nef(135-143)
|
B*53:01, B18 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B*18:01 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B*18:01 human epitope
|
YPLTGWCF
|
Nef(135-143)
|
B*18:01 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*18:01 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*18:01 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*35 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*35 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B*35 human epitope
|
fPLTFGWCY
|
Nef(135-143)
|
observed variant
|
YPLTlGWCY
|
Nef(135-143)
|
escape documented in this paper
|
YPLcFGWCY
|
Nef(135-143)
|
escape documented in this paper
|
YPLTFGWCF
|
Nef(135-143)
|
B*35 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B*35 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*35 human epitope
|
YPLcFGWCF
|
Nef(135-143)
|
subtype-specific susceptible form
|
YPLTFGWCY
|
Nef(135-143)
|
B*35, B*53:01 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B35 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B35 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B35 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B35 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B35 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*35:01 human epitope
|
fPLTFGWCF
|
Nef(135-143)
|
observed variant; replicative capacity reduced
|
lPLTFGWCF
|
Nef(135-143)
|
observed variant; replicative capacity is not abrogated; susceptible form
|
YPLTFGWCY
|
Nef(135-143)
|
B*35:01 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*35:01 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B*35:01, B*35:08 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*35:01, B*53:01 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*35:02, B*35:03, B*53:01 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B*35:02, B*35:03, B*53:01 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B*49 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B49 human epitope
|
YPLTFGWCf
|
Nef(135-143)
|
observed variant
|
YLPTFGWCY
|
Nef(135-143)
|
B49 human epitope
|
YLPTFGWCf
|
Nef(135-143)
|
observed variant
|
YPLTFGWCY
|
Nef(135-143)
|
B49 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B49 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*53 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*53 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B53 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B53 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*53:01 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B*53:01 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*53:01 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B*53:01 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*53:01 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B*53:01 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*53:01 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*57 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*58:01 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B*67:01 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
B7 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B7 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
B7 supertype human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
C*02 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
C*04 human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
C*07:02 human epitope
|
YPLTFGWCF
|
Nef(135-143)
|
human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
human epitope
|
YPLTFGWCY
|
Nef(135-143)
|
human epitope
|
YPLTFGWCFKLVPV
|
Nef(135-148)
|
human epitope
|
YPLTFGWCFKLVPV
|
Nef(135-148)
|
human epitope
|
PLTFGWCYK
|
Nef(136-144)
|
A3 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
A*02 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
A*02 human epitope
|
PLTFGWCFKL
|
Nef(136-145)
|
A*02 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
A*02 human epitope
|
PLcFGWCfKL
|
Nef(136-145)
|
subtype-specific non-susceptible form
|
PLTFGWCYKL
|
Nef(136-145)
|
A*02 human epitope
|
PLcFGWCfKL
|
Nef(136-145)
|
observed variant
|
PLcF(a)GWCfKL
|
Nef(136-145)
|
observed variant
|
PLTFGWCYKL
|
Nef(136-145)
|
A*02 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
A*02 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
A*02:01 human epitope
|
PLTFGWCFKL
|
Nef(136-145)
|
A*02:01 transgenic mouse epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
A*02:01 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
A*02:01 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
A*02:01 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
A2 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
A2 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
A2 human epitope
|
PLTFGWCFKL
|
Nef(136-145)
|
A2 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
A2 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
A*32 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
B*07 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
B*18 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
B*35:02, B*35:03, B*53:01 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
B*49 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
B*58:01 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
C*14 human epitope
|
PLTFGWCYKL
|
Nef(136-145)
|
human epitope
|
PLTFGWCFKL
|
Nef(136-145)
|
human epitope
|
PLTFGWCyKL
|
Nef(136-145)
|
observed variant
|
PLTFGWCFKL
|
Nef(136-145)
|
human epitope
|
PLTLGWCFKL
|
Nef(136-145)
|
observed variant
|
PITFGWCFKL
|
Nef(136-145)
|
susceptible form
|
PVTFGWCFKL
|
Nef(136-145)
|
susceptible form
|
PLCFGWCFKL
|
Nef(136-145)
|
susceptible form
|
PVCFGWCFKL
|
Nef(136-145)
|
observed variant
|
PMCFGWCFKL
|
Nef(136-145)
|
susceptible form
|
PLCFGWCFKP
|
Nef(136-145)
|
susceptible form
|
PLTFGWCFKL
|
Nef(136-145)
|
human epitope
|
PLTFGWCYKLV
|
Nef(136-146)
|
A*02:01 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
A*02 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
A*02:01 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
A*02:01 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
A*02:01 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
A*02:01 mouse epitope
|
LTFGWCFKL
|
Nef(137-145)
|
A2 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
A2 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
A2 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
A2 human epitope
|
LTFGWCYKL
|
Nef(137-145)
|
A2 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
A*23 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
A*25 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
A2 supertype human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
A2 supertype human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
A*32 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
A*68:02 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
A*80 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
B*15:17, B57 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
B*15:40 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
B*57 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
B*57 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
B*63 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
C*14 human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
human epitope
|
LTFGWCFKL
|
Nef(137-145)
|
human epitope
|
LTFGWCFKLV
|
Nef(137-146)
|
A2 human epitope
|
LTFGWCFKLV
|
Nef(137-146)
|
A2 human epitope
|
LTFGWCFKLV
|
Nef(137-146)
|
A2 human epitope
|
LTFGWCFKLV
|
Nef(137-146)
|
A2 human epitope
|
LTFGWCFKLV
|
Nef(137-146)
|
A2 human epitope
|
LTFGWCFKLV
|
Nef(137-146)
|
A2 human epitope
|
LTFGWCFKLV
|
Nef(137-146)
|
A*23 human epitope
|
LTFGWCFKLV
|
Nef(137-146)
|
A2 supertype human epitope
|
LTFGWCFKLV
|
Nef(137-146)
|
A*32 human epitope
|
LTFGWCFKLV
|
Nef(137-146)
|
A*68:02 human epitope
|
LTFGWCFKLV
|
Nef(137-146)
|
A*80 human epitope
|
LTFGWCFKLV
|
Nef(137-146)
|
B*15:17 human epitope
|
LTFGWCYKLV
|
Nef(137-146)
|
human epitope
|
LTFGWCFKLVPVEPEKVE
|
Nef(137-154)
|
human epitope
|
WCFKLVPV
|
Nef(141-148)
|
A2 human epitope
|
WCFKLVPV
|
Nef(141-148)
|
A2 human epitope
|
WCyKLVPV
|
Nef(141-148)
|
observed variant
|
WCFKLVPV
|
Nef(141-148)
|
A2 human, transgenic mouse epitope
|
CYKLVPVEPDKVEEANKGEN
|
Nef(142-161)
|
human epitope
|
FKLVPVDPEEVEEAN
|
Nef(143-157)
|
human epitope
|